Table 2. Sub-group analysis of cervical cancer screening utilization in Ethiopia: A meta-analysis.
| Subgroup type | Category | No of studies | Prevalence(95%CI) | I2 | P-value |
|---|---|---|---|---|---|
| Study design | FBCS | 12 | 17.54 (13.16,21.93) | 94.6% | <0.0001 |
| CBCS | 13 | 12.29 (8.70,15.88) | 98.0% | <0.0001 | |
| Region | Addis Ababa | 4 | 14.32 (8.09,20.56) | 93.7% | <0.0001 |
| Amhara | 9 | 13.62 (9.92,17.32) | 94.5% | <0.0001 | |
| SNNPR | 5 | 18.59 (9.65,27.53) | 97.3% | <0.001 | |
| Oromia | 4 | 16.00 (6.31, 25.7) | 97.1% | <0.001 | |
| Tigray | 2 | 15.41 (6.5, 24.32) | 93.3% | <0.001 | |
| National level | 1 | 2.9 (2.47,3.33) | - | ||
| Women characteristics | HIV positive | 5 | 20.71 (12.8,28.63) | 96.6% | <0.0001 |
| All women | 12 | 11.54 (8.00, 15.05) | 97.9% | <0.0001 | |
| Healthcare workers | 4 | 12.21 (8.71,15.71) | 72.4% | 0.012 | |
| Commercial sex worker | 1 | 13.28 (10.2,16.36) | - | - |